Association des Troubles Psychotiques à la Rétinite Pigmentaire

Auteur/ices

  • Mehdi Boutheina
  • Boutheina Mehdi
  • Anwar Mechri
  • Leila Gassab
  • Salim Ben Yahia
  • Moncef Khiarallah
  • Lotfi Gaha

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Références

Berson EL, Rosner B, Sandberg MA et al. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophtalmol 2004;122:1306-14.

Citver AS, Shields AM, Ciaccia LM, Schulingkamp RJ, Raffa RB. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids. J Clin Pharm Ther 2002;27:161-8.

Daghfous MT, Ayed S, Ben Nejma L. Heredity in pigmented retinopathy. Tunis Med 1987;65:133-5.

Fain GL, Lisman JE. Photoreceptor degeneration in vitamin A deprivation and retinitis pigmentosa: the equivalent light hypothesis. Exp Eye Res 1993;57:335-40.

Goodman AB. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci USA 1998;95:7240-4.

Goodman AB. Chromosomal locations and modes of action of genes of the retinoid (vitamin A) system support their involvement in the etiology of schizophrenia. Am J Med Genet 1995;60:335-48.

Hess-Röver J, Crichton J, Byrne K, Holland AJ. Diagnosis and treatment of a severe psychotic illness in a man with dual severe sensory impairments caused by the presence of Usher syndrome. J Intellect Disabil Res 1999;43:428-34.

Téléchargements

Publiée

2010-04-05

Numéro

Rubrique

lettres a la redaction